Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

HealSun Biopharm

Request full access

Healsun Biopharm is a pharmaceutical company

Hangzhou, ChinaFounded 2015Biotech & Life Sciences

About HealSun Biopharm

HS Biopharm operates in the biopharmaceutical industry, focusing on the development and optimization of CHO (Chinese Hamster Ovary) cell lines for the production of therapeutic proteins and monoclonal antibodies. The company serves pharmaceutical and biotechnology clients who require high-quality cell lines for drug development and manufacturing. HS Biopharm's business model revolves around providing end-to-end solutions, from DNA transfection to commercial-scale production, ensuring high yield and quality. Revenue is generated through project-based contracts and long-term partnerships with clients. The company leverages advanced technologies and proprietary methodologies to optimize cell culture processes, including pH and temperature shifts, seed density adjustments, and bioreactor tuning. This approach allows for efficient and scalable production, meeting the stringent regulatory requirements of the biopharmaceutical market.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
23.3/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Nov 2025 $44M $550M Betta Pharmaceuticals ↗
SERIES BOther financing Oct 2023 $28M $481M China Medical System Holdings · Oriental Fortune ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

HealSun Biopharm website traffic

Latest recorded traffic for HealSun Biopharm is 1K monthly website visits, up 376.2% over the last three months.

Latest monthly visits1K 3-month web change+376.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

HealSun Biopharm in the Hangzhou ecosystem

Live from Dealroom

The HealSun Biopharm office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Sinowisdom
  • Haibang Capital
  • Yinxinggu Capital
  • Shanghai Biomedical Industrial Equity Investment Fund
  • HT Capital
  • Xinghua Dingli
  • China Medical System Holdings
  • Oriental Fortune

Series B and later1 investor entered at this stage

  • Betta Pharmaceuticals
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about HealSun Biopharm on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See HealSun Biopharm’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.